Status:
COMPLETED
Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis
Lead Sponsor:
Children's Mercy Hospital Kansas City
Conditions:
Perforated Appendicitis
Eligibility:
All Genders
Up to 18 years
Phase:
NA
Brief Summary
The objective of this study is to scientifically evaluate two different management strategies for perforated appendicitis. The hypothesis is that early discharge with oral antibiotic therapy may resu...
Detailed Description
This will be a single institution, prospective, randomized clinical trial involving patients who present to the hospital with perforated appendicitis. This will be a definitive study. Power calculati...
Eligibility Criteria
Inclusion
- Identifiable hole in the appendix or stool in the abdomen at the time of appendectomy
Exclusion
- Known immune deficiency
- Abscess identified on pre-op imaging
- Another condition affecting surgical decision making or recovery (e.g. hemophilia, severe cardiac or respiratory co-morbidities).
Key Trial Info
Start Date :
March 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2008
Estimated Enrollment :
102 Patients enrolled
Trial Details
Trial ID
NCT00462020
Start Date
March 1 2007
End Date
November 1 2008
Last Update
February 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Mercy Hospital
Kansas City, Missouri, United States, 64108